A Retrospective Observational Study to Investigate the Prevalence of NTRK gene fusion positive in Solid Tumor in Japa
Not Applicable
- Conditions
- Advanced solid tumor
- Registration Number
- JPRN-UMIN000050715
- Lead Sponsor
- Bayer Yakuhin, Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 46745
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of patients with NTRK gene fusions by patient characteristic categories, such as tumor types. Distribution of cancer types in patients with NTRK fusion positive among all, adult and pediatric
- Secondary Outcome Measures
Name Time Method